![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD) was organized to support the translation of basic research achievements into clinical practice and to bridge the gap between academic studies and innovations of pharmacologic companies. A clear discrepancy between high rates of immune anti-tumor responses and poor clinical effects makes necessary to improve cancer vaccination. This challenge stimulated a fruitful discussion on strategies of immunization, adjuvants, delivery systems, novel antigens, targets and monitoring of the immune response.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.